202 related articles for article (PubMed ID: 12946225)
1. Giant cell glioblastoma and pleomorphic xanthoastrocytoma show different immunohistochemical profiles for neuronal antigens and p53 but share reactivity for class III beta-tubulin.
Martinez-Diaz H; Kleinschmidt-DeMasters BK; Powell SZ; Yachnis AT
Arch Pathol Lab Med; 2003 Sep; 127(9):1187-91. PubMed ID: 12946225
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotype of pleomorphic xanthoastrocytoma.
Giannini C; Scheithauer BW; Lopes MB; Hirose T; Kros JM; VandenBerg SR
Am J Surg Pathol; 2002 Apr; 26(4):479-85. PubMed ID: 11914626
[TBL] [Abstract][Full Text] [Related]
3. Divergent differentiation in pleomorphic xanthoastrocytoma. Evidence for a neuronal element and possible relationship to ganglion cell tumors.
Powell SZ; Yachnis AT; Rorke LB; Rojiani AM; Eskin TA
Am J Surg Pathol; 1996 Jan; 20(1):80-5. PubMed ID: 8540612
[TBL] [Abstract][Full Text] [Related]
4. BRAF-mutated pleomorphic xanthoastrocytoma is associated with temporal location, reticulin fiber deposition and CD34 expression.
Koelsche C; Sahm F; Wöhrer A; Jeibmann A; Schittenhelm J; Kohlhof P; Preusser M; Romeike B; Dohmen-Scheufler H; Hartmann C; Mittelbronn M; Becker A; von Deimling A; Capper D
Brain Pathol; 2014 Apr; 24(3):221-9. PubMed ID: 24345274
[TBL] [Abstract][Full Text] [Related]
5. Pleomorphic xanthoastrocytoma with gangliogliomatous component.
Vajtai I; Varga Z; Aguzzi A
Pathol Res Pract; 1997; 193(9):617-21. PubMed ID: 9521020
[TBL] [Abstract][Full Text] [Related]
6. MGMT Promoter Methylation and BRAF V600E Mutations Are Helpful Markers to Discriminate Pleomorphic Xanthoastrocytoma from Giant Cell Glioblastoma.
Lohkamp LN; Schinz M; Gehlhaar C; Guse K; Thomale UW; Vajkoczy P; Heppner FL; Koch A
PLoS One; 2016; 11(6):e0156422. PubMed ID: 27253461
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic study of pleomorphic xanthoastrocytoma of brain].
Li NY; Zhou J; Zhou HB; Ma HH
Zhonghua Bing Li Xue Za Zhi; 2006 Aug; 35(8):453-7. PubMed ID: 17069696
[TBL] [Abstract][Full Text] [Related]
8. pRB immunostaining in the differential diagnosis between pleomorphic xanthoastrocytoma and glioblastoma with giant cells.
Barresi V; Simbolo M; Ciaparrone C; Pedron S; Mafficini A; Scarpa A
Histopathology; 2022 Nov; 81(5):661-669. PubMed ID: 35945679
[TBL] [Abstract][Full Text] [Related]
9. Pleomorphic xanthoastrocytoma as a component of a temporal lobe cystic ganglioglioma: a case report.
Sugita Y; Irie K; Ohshima K; Hitotsumatsu T; Sato O; Arimura K
Brain Tumor Pathol; 2009; 26(1):31-6. PubMed ID: 19408095
[TBL] [Abstract][Full Text] [Related]
10. Intraventricular pleomorphic xanthoastrocytoma with anaplastic features.
Fu YJ; Miyahara H; Uzuka T; Natsumeda M; Okamoto K; Hirose T; Fujii Y; Takahashi H
Neuropathology; 2010 Aug; 30(4):443-8. PubMed ID: 20051018
[TBL] [Abstract][Full Text] [Related]
11. Temporal pleomorphic xanthoastrocytoma with glycogen accumulation--case report.
Rogério F; Queiroz Lde S; de Lima MS; Kaleff PR; Vargas AA
Clin Neuropathol; 2008; 27(4):234-40. PubMed ID: 18666439
[TBL] [Abstract][Full Text] [Related]
12. Pleomorphic xanthoastrocytoma - a clinico-pathological review.
Sharma A; Nand Sharma D; Kumar Julka P; Kishor Rath G
Neurol Neurochir Pol; 2011; 45(4):379-86. PubMed ID: 22101999
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and genetic association between epithelioid glioblastoma and pleomorphic xanthoastrocytoma.
Furuta T; Miyoshi H; Komaki S; Arakawa F; Morioka M; Ohshima K; Nakada M; Sugita Y
Neuropathology; 2018 Jun; 38(3):218-227. PubMed ID: 29532523
[TBL] [Abstract][Full Text] [Related]
14. Aberrant localization of the neuronal class III beta-tubulin in astrocytomas.
Katsetos CD; Del Valle L; Geddes JF; Assimakopoulou M; Legido A; Boyd JC; Balin B; Parikh NA; Maraziotis T; de Chadarevian JP; Varakis JN; Matsas R; Spano A; Frankfurter A; Herman MM; Khalili K
Arch Pathol Lab Med; 2001 May; 125(5):613-24. PubMed ID: 11300931
[TBL] [Abstract][Full Text] [Related]
15. Pleomorphic xanthoastrocytoma: a developmental glioneuronal tumor with prominent glioproliferative changes.
Im SH; Chung CK; Kim SK; Cho BK; Kim MK; Chi JG
J Neurooncol; 2004 Jan; 66(1-2):17-27. PubMed ID: 15015766
[TBL] [Abstract][Full Text] [Related]
16. Pleomorphic xanthoastrocytoma with a gangliomatous component: an immunohistochemical and ultrastructural study.
Kordek R; Biernat W; Sapieja W; Alwasiak J; Liberski PP
Acta Neuropathol; 1995; 89(2):194-7. PubMed ID: 7732793
[TBL] [Abstract][Full Text] [Related]
17. Expression of diagnostic neuronal markers and outcome in glioblastoma.
Donev K; Scheithauer BW; Rodriguez FJ; Jenkins S
Neuropathol Appl Neurobiol; 2010 Aug; 36(5):411-21. PubMed ID: 20298476
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical characterization of subependymal giant cell astrocytomas.
Lopes MB; Altermatt HJ; Scheithauer BW; Shepherd CW; VandenBerg SR
Acta Neuropathol; 1996; 91(4):368-75. PubMed ID: 8928613
[TBL] [Abstract][Full Text] [Related]
19. Pleomorphic xanthoastrocytoma: MR imaging findings in 19 patients.
Yu S; He L; Zhuang X; Luo B
Acta Radiol; 2011 Mar; 52(2):223-8. PubMed ID: 21498352
[TBL] [Abstract][Full Text] [Related]
20. Morphological features of gliomas in children.
Hirato J; Nakazato Y
Noshuyo Byori; 1996 Apr; 13(1):37-47. PubMed ID: 8916125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
